MedTrace Logo

Magnetic Resonance Imaging and Spectroscopy of the Prostate

NCT00590993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1005

Last updated 2023-10-24

No results posted yet for this study

Summary

Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.

Conditions

Interventions

OTHER

MRI and MRSI

Compare treatment impact when using MRI and MRSI

Sponsors & Collaborators

Principal Investigators

  • Hedvig Hricak, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590993 on ClinicalTrials.gov